Areas of interest

As Santen works to discover new drug candidates through our own research capabilities, we also welcome collaborations with other external resources that may offer mutually beneficial partnership opportunities.

Our core R&D strategy focuses our resources on therapeutic areas offering the most potential for growth and the best opportunity to fully utilize our strengths. To this end, we are pursuing new drug development targeted on:

Santen's unique method of "network-based drug discovery" seeks to take advantage of the knowledge available from other pharmaceutical companies and research institutions. When the entrepreneurial goals of these organizations align with our own thematic R&D focus—or when they offer unexpected pathways to broaden it—we want to hear from them.